Retinoschisin secretion into the conditioned medium is decreased by addition of cytochalasin D. by Eiko Kitamura (349087)

“…(D) Retinoschisin secretion decreases in a dose-dependent manner by treatment of cells with cytochalasin D at concentrations between 0.5 µM and 2 µM. …”

NDRG2 is decreased during LX-2 activation. by Jiandong Yang (196004)

AA-deficient <i>sfx</i> mice had decreased articular cartilage. by Richard C. Lindsey (7148168)

Activation of NMDA receptors with D-serine obviously limited the decrease of p-CREB in the hippocampus of the surviving LPS-treated mice. by Shuibing Zhang (4336402)

Cytochalasin D decreases pyroptosis in TLR ligand-activated Raw264.7 cells. by Peeraya Ekchariyawat (3911113)

FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

“…<p>(A) HuH6 cells (2.5 x 10⁶ cells in 25% Matrigel) were injected subcutaneously into the right flank of 6-week-old female athymic nude mice. …”

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)

PIKfyve inhibition results in decreased melanin accumulation and decreased accumulation of advanced stage melanosomes. by Marc C. Liggins (5018390)

GSH depletion leads to a strong decrease in SCF-dependent HIF-1α PHD activity in LAD2 cells. by Bernhard F. Gibbs (328262)

Sepsis decreases the frequencies of CD4 T cells. by Mian Zhou (339595)

Inhibition of G9a decreases the tumorigenicity of neuroblastoma cells. by Xiao-Xue Ke (626989)

Skp2 protein levels decrease upon RalGPS2 depletion. by Adriana O. Santos (2697097)

The recruitment of MYD88 to TLR2 and IRAK-4 phosphorylation are decreased in β3-integrin–silenced cells. by Tatiana Gianni (499634)

Decreased oligodendrocyte precursor number in developing white matter tracts. by Mark D. Grier (726986)

HRMECs treated with 3-Deazaneplanocin A (DZNep) chemical inhibitor demonstrated increased miR-200b and decreased VEGF expression. by Michael Anthony Ruiz (726055)

“…[NG = 5mM D-glucose, HG = 25mM D-glucose, NG+DMSO = 5mM D-glucose + 0.05% DMSO, HG+DMSO = 25mM D-glucose + 0.05% DMSO, NG+DZNEP = 5mM D-glucose + 5μM DZNep, HG+DZNEP = 25mM + 5μM DZNep; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to β-actin for VEGF and U6 for miR-200b, expressed as a fold change of NG].…”

Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

“…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”

RL2 decreases viability and induces apoptosis in cultured cells. by Olga A. Koval (548122)

RNA interference-mediated decrease in Ixofin3D results in decreased <i>B. burgdorferi</i> burden in the salivary glands and in murine skin. by Sukanya Narasimhan (73432)

Glucocorticoid receptor knockdown is associated with a decrease in nuclear Nrf2. by Elena Obrador (559979)

Decreased mRNA levels of inflammatory cytokines from <i>cpdm</i> BMDC. by Zhe Wang (41178)